Leaderboards/Medicinal Plant Pharmacodynamics Research

Medicinal Plant Pharmacodynamics Research

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Deng Huifen
Unknown
2
Ciliang Guo
Chinese Academy of Sciences
3
Yuhao Si
Nanjing University of Chinese Medicine
4
Xin Ba
Tongji Hospital
5
Zining Yu
Shangrao Normal University
6
Yaolong Zhou
Huashan Hospital
7
Beibei Wu
Central South University
8
Jiawen Tang
University of Science and Technology Beijing
9
Xiangyu Meng
University College Dublin
10
Haoran Zhang
Houston Methodist

Papers

1
Publication in Free Radical Biology and Medicine (2024) [58 citations, W4401876455]
Free Radical Biology and Medicine|2024
58 cit.
2
Publication in Biomedicine & Pharmacotherapy (2024) [51 citations, W4392672341]
Biomedicine & Pharmacotherapy|2024
51 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Shensheng Nian
Second Military Medical University
2
Basma G. Eid
King Abdulaziz University
3
Nicholas Chew
National University Health System
4
Guoan Shen
Institute of Medicinal Plant Development
5
Wu Zhou
Union Hospital
6
Liangdong Li
Gannan Medical University
7
Shin‐Hyung Park
Kyungpook National University Hospital
8
Yanpeng Liu
Westlake University
9
Amir I. Mohamed
Military Medical Academy
10
Zhihe Liu
Jinan University

Papers

1
The global burden of metabolic disease: Data from 2000 to 2019
Cell Metabolism|2023
764 cit.
2
Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019
EClinicalMedicine|2023
300 cit.
3
The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000–2019
Metabolism|2023
159 cit.
4
The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions
The Lancet Regional Health - Western Pacific|2024
77 cit.
5
Icaritin inhibits neuroinflammation in a rat cerebral ischemia model by regulating microglial polarization through the GPER–ERK–NF-κB signaling pathway
Molecular Medicine|2022
75 cit.
6
Long-Term Prognosis of Patients With Coexisting Obesity and Malnutrition After Acute Myocardial Infarction: A Cohort Study
Circulation Cardiovascular Quality and Outcomes|2023
42 cit.
7
Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population
Diabetes Research and Clinical Practice|2024
42 cit.
8
Piceatannol Affects Gastric Ulcers Induced by Indomethacin: Association of Antioxidant, Anti-Inflammatory, and Angiogenesis Mechanisms in Rats
Life|2022
36 cit.
9
The Global Syndemic of Modifiable Cardiovascular Risk Factors Projected From 2025 to 2050
Journal of the American College of Cardiology|2025
34 cit.
10
Trends and predictions of metabolic risk factors for acute myocardial infarction: findings from a multiethnic nationwide cohort
The Lancet Regional Health - Western Pacific|2023
32 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Robert D. Schreiber
Parker Institute for Cancer Immunotherapy
2
Jason S. Carroll
Cancer Research UK Cambridge Center
3
Carlos Caldas
University of Cambridge
4
Jingcheng Dong
Fudan University
5
Ling Qin
First Affiliated Hospital of Henan University of Science and Technology
6
Yijia Lou
Peking University
7
Warren S. Alexander
The University of Melbourne
8
Yoichiro Ito
National Institutes of Health
9
Kwang Seok Ahn
Kyung Hee University
10
Qihai Gong
Zunyi Medical University

Papers

1
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Nature|2001
2.8k cit.
2
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
Nature|2012
2.4k cit.
3
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Nature|2014
2k cit.
4
Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway
Cell|1996
1.7k cit.
5
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Proceedings of the National Academy of Sciences|1998
1.4k cit.
6
Chromosome-Wide Mapping of Estrogen Receptor Binding Reveals Long-Range Regulation Requiring the Forkhead Protein FoxA1
Cell|2005
1.4k cit.
7
Adaptive immunity maintains occult cancer in an equilibrium state
Nature|2007
1.4k cit.
8
Genome-wide analysis of estrogen receptor binding sites
Nature Genetics|2006
1.4k cit.
9
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Nature|2012
1.3k cit.
10
The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism
Immunity|2013
1.2k cit.

Reagents for Medicinal Plant Pharmacodynamics Research

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 63

ILK1 (4G9) Rabbit Monoclonal Antibody

#3856$177,409
View Evidence →
Cell Signaling TechnologyEvidence 68

Tyk2 Antibody

#9312$394
View Evidence →
Cell Signaling TechnologyEvidence 61

Phospho-FLT3 (Tyr842) (10A8) Rabbit Monoclonal Antibody

#4577$179,411
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

PathScan® Phospho-Chk1 (Ser317) Sandwich ELISA Kit

Cited in 5 papers
#7870$66,129,740
View Evidence →
Cell Signaling TechnologyEvidence 64

Cleaved Caspase-9 (Asp330) (D2D4) Rabbit Monoclonal Antibody

#7237$169,415
View Evidence →
Cell Signaling TechnologyEvidence 65

Cleaved Caspase-9 (Asp315) (D8I9E) Rabbit Monoclonal Antibody

#20750$178,412
View Evidence →